A Constrained Hierarchical Bayesian Model Considering Latent Biomarker Subgroups for Time‐To‐Event Endpoints in Randomized Phase II Trials
Year: 2026
Type: article
Source: Pharmaceutical Statistics
DOI: 10.1002/pst.70085
Authors: Yifei Huang, Kentaro Takeda, Yongyun Zhao
Institution: Astellas Pharma (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W7142855069